Combined Mesenchymal Stem Cells and Cartilage Acellular Matrix Injection Therapy for Osteoarthritis in Goats

Overview

Journal Tissue Eng Regen Med

Date 2022 Jan 13

PMID 35023025

Authors

Mijin Kim

Jongchan Ahn

Jusik Lee

Seongsoo Song

Seunghee Lee

Kyung-Sun Kang

Affiliations

Soon will be listed here.

Abstract

Background: Human umbilical cord blood-derived MSCs (hUCB-MSCs) have been studied in osteoarthritis (OA) and cartilage regeneration. Our previous study demonstrated that hUCB-MSCs combined with cartilage acellular matrix injection (CAM Inj.) represent potential therapeutic agents for structural improvement and anti-inflammatory effects in a rabbit model of OA.

Methods: Based on a previous study, this study has evaluated the safety and efficacy of hUCB-MSCs combined with CAM Inj. in an anterior cruciate ligament transection (ACLT) with medial meniscectomy (MMx) in a goat model. In this study, 27 goats were divided into 5 groups: normal (n = 3), OA (n = 6), OA + CAM Inj. (n = 6), OA + hUCB-MSCs (n = 6), and OA + hUCB-MSCs + CAM Inj. (n = 6). Lameness and radiographic parameters were assessed 6 months after administration, and macroscopic and histological evaluations of the goat articular cartilage were performed 6 months after intervention.

Results: The results showed significant improvement in lameness score only in the OA + hUCB-MSCs group at 5 months after treatment (*p < 0.05), whereas the K&L score showed significant improvement only in the OA + hUCB-MSCs + CAM Inj. group 6 months after intervention (*p < 0.05). In addition, the gross findings showed significance in OA + CAM Inj. and OA + hUCB-MSCs + CAM Inj. groups 6 months after treatment (*p < 0.05 and **p < 0.01).

Conclusion: In conclusion, treatment with a combination of hUCB-MSCs and CAM Inj. reduced OA symptoms and induced effective cartilage tissue repair in a goat model. We suggest the combination of hUCB-MSCs and CAM Inj. as an alternative therapy for OA.

Citing Articles

ACL injury management: a comprehensive review of novel biotherapeutics.

Yu X, Hu J, Li Y, Wen Y, Li B Front Bioeng Biotechnol. 2024; 12:1455225.

PMID: 39650235 PMC: 11620901. DOI: 10.3389/fbioe.2024.1455225.

Functional biomaterials for osteoarthritis treatment: From research to application.

Lei Y, Zhang Q, Kuang G, Wang X, Fan Q, Ye F Smart Med. 2024; 1(1):e20220014.

PMID: 39188730 PMC: 11235767. DOI: 10.1002/SMMD.20220014.

Therapeutic effects of different intervention forms of human umbilical cord mesenchymal stem cells in the treatment of osteoarthritis.

Zhang Y, Zhuang H, Ren X, Jiang F, Zhou P Front Cell Dev Biol. 2023; 11:1246504.

PMID: 37635870 PMC: 10448389. DOI: 10.3389/fcell.2023.1246504.

Updates on mesenchymal stem cell therapies for articular cartilage regeneration in large animal models.

Liu T, Ha P, Xiao C, Kim S, Jensen A, Easley J Front Cell Dev Biol. 2022; 10:982199.

PMID: 36147737 PMC: 9485723. DOI: 10.3389/fcell.2022.982199.

References

Pelletier J, Martel-Pelletier J, Rannou F, Cooper C . Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016; 45(4 Suppl):S22-7. DOI: 10.1016/j.semarthrit.2015.11.009. View

Liu Y, Shu X, Prestwich G . Osteochondral defect repair with autologous bone marrow-derived mesenchymal stem cells in an injectable, in situ, cross-linked synthetic extracellular matrix. Tissue Eng. 2007; 12(12):3405-16. DOI: 10.1089/ten.2006.12.3405. View

Zhang R, Ma J, Han J, Zhang W, Ma J . Mesenchymal stem cell related therapies for cartilage lesions and osteoarthritis. Am J Transl Res. 2019; 11(10):6275-6289. PMC: 6834499. View

Lu P, Takai K, Weaver V, Werb Z . Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol. 2011; 3(12). PMC: 3225943. DOI: 10.1101/cshperspect.a005058. View

Moran C, Ramesh A, Brama P, OByrne J, OBrien F, Levingstone T . The benefits and limitations of animal models for translational research in cartilage repair. J Exp Orthop. 2016; 3(1):1. PMC: 4703594. DOI: 10.1186/s40634-015-0037-x. View

Hoemann C, Hurtig M, Rossomacha E, Sun J, Chevrier A, Shive M . Chitosan-glycerol phosphate/blood implants improve hyaline cartilage repair in ovine microfracture defects. J Bone Joint Surg Am. 2005; 87(12):2671-2686. DOI: 10.2106/JBJS.D.02536. View

Yin H, Wang Y, Sun Z, Sun X, Xu Y, Li P . Induction of mesenchymal stem cell chondrogenic differentiation and functional cartilage microtissue formation for in vivo cartilage regeneration by cartilage extracellular matrix-derived particles. Acta Biomater. 2016; 33:96-109. DOI: 10.1016/j.actbio.2016.01.024. View

Kilmer C, Battistoni C, Cox A, Breur G, Panitch A, Liu J . Collagen Type I and II Blend Hydrogel with Autologous Mesenchymal Stem Cells as a Scaffold for Articular Cartilage Defect Repair. ACS Biomater Sci Eng. 2021; 6(6):3464-3476. PMC: 8287628. DOI: 10.1021/acsbiomaterials.9b01939. View

Wang M, Yang Y, Yang D, Luo F, Liang W, Guo S . The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology. 2008; 126(2):220-32. PMC: 2632684. DOI: 10.1111/j.1365-2567.2008.02891.x. View

10.

Chanda D, Kumar S, Ponnazhagan S . Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton. J Cell Biochem. 2010; 111(2):249-57. PMC: 2946500. DOI: 10.1002/jcb.22701. View

11.

Howard D, Buttery L, Shakesheff K, Roberts S . Tissue engineering: strategies, stem cells and scaffolds. J Anat. 2008; 213(1):66-72. PMC: 2475566. DOI: 10.1111/j.1469-7580.2008.00878.x. View

12.

Arroll B, Goodyear-Smith F . Corticosteroid injections for osteoarthritis of the knee: meta-analysis. BMJ. 2004; 328(7444):869. PMC: 387479. DOI: 10.1136/bmj.38039.573970.7C. View

13.

Loeser R, Goldring S, Scanzello C, Goldring M . Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012; 64(6):1697-707. PMC: 3366018. DOI: 10.1002/art.34453. View

14.

Altman R, Manjoo A, Fierlinger A, Niazi F, Nicholls M . The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet Disord. 2015; 16:321. PMC: 4621876. DOI: 10.1186/s12891-015-0775-z. View

15.

Kim J, Jeon H, Yang Y, Oh W, Chang J . Application of human umbilical cord blood-derived mesenchymal stem cells in disease models. World J Stem Cells. 2011; 2(2):34-8. PMC: 3097922. DOI: 10.4252/wjsc.v2.i2.34. View

16.

Burnsed O, Schwartz Z, Marchand K, Hyzy S, Olivares-Navarrete R, Boyan B . Hydrogels derived from cartilage matrices promote induction of human mesenchymal stem cell chondrogenic differentiation. Acta Biomater. 2016; 43:139-149. DOI: 10.1016/j.actbio.2016.07.034. View

17.

Harrell C, Markovic B, Fellabaum C, Arsenijevic A, Volarevic V . Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives. Biomed Pharmacother. 2018; 109:2318-2326. DOI: 10.1016/j.biopha.2018.11.099. View

18.

Xu X, Liang Y, Li X, Ouyang K, Wang M, Cao T . Exosome-mediated delivery of kartogenin for chondrogenesis of synovial fluid-derived mesenchymal stem cells and cartilage regeneration. Biomaterials. 2020; 269:120539. DOI: 10.1016/j.biomaterials.2020.120539. View

19.

Khajavi M, Hajimoradloo A, Zandi M, Pezeshki-Modaress M, Bonakdar S, Zamani A . Fish cartilage: A promising source of biomaterial for biological scaffold fabrication in cartilage tissue engineering. J Biomed Mater Res A. 2021; 109(9):1737-1750. DOI: 10.1002/jbm.a.37169. View

20.

Shimizu M, Higuchi H, Takagishi K, Shinozaki T, Kobayashi T . Clinical and biochemical characteristics after intra-articular injection for the treatment of osteoarthritis of the knee: prospective randomized study of sodium hyaluronate and corticosteroid. J Orthop Sci. 2010; 15(1):51-6. DOI: 10.1007/s00776-009-1421-0. View